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Abstract
It is important for public health professionals to understand the effects of vaccine introduction
and compare different types of vaccinations. This study will focus on understanding the pre and
post vaccination effects of two different infectious diseases: pneumonia and gastrointestinal
disorders. One of approaches of getting the accurate estimate of vaccine impact is by comparing
rates or trends of the targeted disease in the years after introduction with rates of trend in the
year before introduction using a time-series analysis. Specifically, in this study, the synthetic
controls method implements an approach to estimating the causal effect of a designed
intervention on a time series. With this new approach, potential comparison time series are
combined into a composite and are used to generate a counterfactual estimate, which can be
compared with the time series of interest, which are effect of vaccines on pneumonia or
gastrointestinal disorders after the intervention. After conducting time series analysis on five
different regions of Brazil and in national level, this study finds that the introduction of
pneumonia vaccine in five regions of Brazil results in a significant increasing in case prevented
and decreasing in observed cases compared to synthetic control estimated cases. However, unlike
pneumonia vaccine, introduction of gastrointestinal disorder vaccine is not significantly effective
for certain region of Brazil in both age groups.
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Introduction
Vaccination, as an epidemiological intervention, is important to keep infectious diseases from
spreading. After vaccination, public health practitioners will monitor the infectious disease rate in
order to make sure that the vaccine is effective and beneficial to the community. One of
approaches of getting the accurate estimate of vaccine impact is by comparing rates or trends of
the targeted disease in the years after introduction with rates of trend in the year before
introduction using a time-series analysis.[1]
Before the introduction of vaccination in the United States, rotavirus caused about 2.7 million
cases of severe gastroenteritis in children, almost 60,000 hospitalizations, and around 37 deaths
per year.[2] At the same time, also in the United States, pneumonia accounts for 3–18% of all
childhood hospital admissions.[1] For people aged 65 years or older, nearly one million episodes
of community-acquired pneumonia occur every year, with 40% resulting in admission.[3] In the
developing countries, pneumonia still remains a leading cause of death across different age
groups.[4] Introduction of a new vaccine is expected to provide direct protection for suspected
population by immunizing individuals. The suspected population could also be indirectly
protected from herd immunity because of the increasing number of vaccinated individuals.
Therefore, the spreading of the infectious disease could be controlled and the admission number
of hospitalization caused by infection would be averted significantly. In our study, both effects of
rotavirus and pneumococcal vaccines are measured based on the hospitalization data.
Instead of focusing on the seasonal changes of infectious disease, this study is controlled for
seasonality while estimating the total effect (direct & indirect) of these vaccines across different
age groups based on the data of hospitalization. Data were collected at the national and regional
4

level of Brazil with the outcomes of either pneumonia or gastrointestinal disorders including both
pre and post-vaccination. Comparison of rotavirus vaccine and pneumonia vaccine effects on
gastrointestinal disorders and pneumonia will be conducted to generate evidence on public
health impact. The aversion of hospitalization admission is used as the end point to estimate the
effect of vaccines.
In this study, the synthetic controls method, which was originally developed and named as
“Casual impact” in R package, which implements an approach to estimating the causal effect of a
designed intervention on a time series. This method is based on the assumption that there is a
set of control time series that were themselves not affected by the intervention, which in our
study is that control infectious diseases were not affected by the introduced vaccines. With this
new approach, potential comparison time series are combined into a composite and are used to
generate a counterfactual estimate, which can be compared with the time series of interest,
which are effect of vaccines on pneumonia or gastrointestinal disorders after the intervention.[1]

Methods
Sources of Data
Hospitalization data were obtained from national and regional level data of Brazil across different
age groups from the Hospital Information System administrative database of the National Unified
Health System (SIH-SUS). We expect to include pre-vaccination and post-vaccination
hospitalization data. Targeted individuals were diarrhea-related hospitalization and pneumonia
admission, therefore only these two types of data were needed to be collected and analyzed.
More specifically, based on the International Classification of Diseases (ICD-10), J12-J18 is the
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targeted code for influenza and pneumonia and A00-A09 is the targeted code for intestinal
infectious disease from the hospitalization data.

Definition of pneumonia hospitalization
In this study the following ICD-10 codes are used: J12, viral pneumonia; J13, Streptococcus
pneumoniaecaused pneumonia; J14, Haemophilus influenzaecaused pneumonia; J15, bacterial
pneumonia not otherwise specified; J16, other infectious organism not elsewhere classified; J17,
pneumonia in diseases classified elsewhere; and J18, unspecified organism.[5]

Definition of intestinal infectious disease hospitalization
In this study the following ICD-10 codes are used: A00, Cholera; A01, Typhoid and paratyphoid
fevers; A02, other salmonella infections; A03, Shingellosis; A04, Other bacterial intestinal
infections; A05, Other bacterial foodborne intoxications, not elsewhere classified; A06, Amebiasis;
A07, Other protozoal intestinal diseases; A08, Viral and other specified intestinal infections; A09,
Infections gastroenteritis and colitis, unspecified.[5]

Study Population
The present investigation included children aged under two years old living in Brazil, hospitalized
due to all causes from January 2010 to December 2013, in all five different regions of Brazil:
North, Northeast, Center-West, Southeast and South.
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Controls
Table and definition for controls of synthetic control estimation model
ICD-10 Code for Control

Definition

A17

Tuberculosis of nervous system

A18

Tuberculosis of other organs

A19

Miliary tuberculosis

A39

Meningococcal infection

A41

Other sepsis

B20_24

Human immunodeficiency virus [HIV] disease

B34

Viral infection of unspecified site

B96

Other bacterial agents as the cause of diseases
classified elsewhere

B97

Viral agents as the cause of diseases classified
elsewhere

B99

Other and unspecified infectious diseases

C00_D48

Neoplasms

D50_89

Diseases of the blood and blood-forming
organs and certain disorders involving the
immune mechanism

E00_99

Endocrine, nutritional and metabolic diseases

I00_99

Diseases of the circulatory system

J20_J22

Other acute lower respiratory infections
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K00_99

Diseases of the digestive system

L00_99

Diseases of the skin and subcutaneous tissue

M00_99

Diseases of the musculoskeletal system and
connective tissue

N00_99

Diseases of the genitourinary system

P00_99

Certain conditions originating in the perinatal
period

Q00_99

Congenital malformations, deformations and
chromosomal abnormalities

S00_T99

Injury,

poisoning

and

certain

other

consequences of external causes
V00_Y99

External causes of morbidity

Z00_99

Factors influencing health status and contact
with health services

Significance
Synthetic control model is used to detect and adjust for unmeasured bias and confounding in the
evaluation of vaccine programs.[1] Using data from regional level of Brazil in North, Northeast,
Center-West, Southeast and South, the synthetic control model can evaluate the changing of
hospitalization due to all-cause pneumonia and gastrointestinal disorders with the introduction
of corresponding vaccines. Comparing to other linear regression and time series model, this
method is likely to increase the accuracy and effectively adjust for unexplained trends in the
8

hospitalization data from these five regions of Brazil.

Statistical analysis
Hospitalization data was analyzed through synthetic control method in order to adjust for
seasonal changes and unexpected trends. Because many unexpected factors aside from targeted
vaccination could influence the disease rate, it is necessary to use control diseases to adjust for
unrelated trends. First of all, linear regression model will be used to fit the data from pre-vaccine
hospitalization for establishing a relationship between control and targeted diseases. After that,
post-vaccine data for control disease will be plugged in to predict the estimated targeted disease
value. Finally, the estimated targeted disease hospitalization data will be compared to observed
hospitalization data to obtain the difference. Analyzed results will yield hospitalization incidence
changing in all states of Brazil in different age groups.

Key assumptions:
1. None of the control diseases are influenced by these two vaccines.
2. The relationship between targeted diseases and the control diseases do not change over
time.

Results
We expected to observe changes in incidence from time series analysis generated results in
certain age groups. It is possible that different age groups present different scenarios in the time
series. The differences in hospitalization decline after introduction of vaccines between states in
9

Brazil are likely to be detected from the evidence generated by time series analysis. More
importantly, the declination of hospitalization for gastrointestinal disorders and pneumonia could
be different due to underlying factors like geographic locations, suspected populations,
transmission rate and more.

Comparison of incidence counts in regional and national level of Brazil:
This is the graph to illustrate the different incidence counts of both infectious diseases in
different regions of Brazil and in two different age groups under two years old. Specifically, the
red triangles represent the incidences of gastrointestinal disorders while the blue dots represent
the incidences of pneumonia. The number on the x-axis represents the region number of Brazil,
at the same time A represents the national level incidences of both diseases. According to this
graph, region one incidence counts of both infectious diseases are close to each other with
amount around 50000; region two the incidences of gastrointestinal disorders, which are about
120000, are higher than the incidences of pneumonia, which are about 100000; region three the
incidences of pneumonia are higher than the incidences of gastrointestinal disorders in both age
groups, with larger difference in less than 12 months age group; region four overall the
incidences of pneumonia are higher than the incidences of gastrointestinal disorders in both age
groups as well; region five both incidences of two diseases have similar lower counts than other
regions of Brazil. In the national level, the incidences of both diseases are higher in less than 12
months age groups. Additionally, incidences of pneumonia are higher than gastrointestinal
disorders nationally in Brazil for patients under two years old according to this study.
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Comparison of Adjusted number of cases in regional and national level of Brazil:
This graph is adjusted for the overall hospitalization data of Brazil for pneumonia and
gastrointestinal disorder incidences. Similarly, the red triangles represent the incidences of
gastrointestinal disorders while the blue dots represent the incidences of pneumonia. The
dashed gray line separated the overall graph into two parts: the right part represents the
adjusted number of cases for 12-23 months age group, the left part represents the adjusted
number of cases for under 12 months age group. It is obvious to find out that under 12 months
age group has lower adjusted number of cases, which is below 1.0, in all regions of Brazil
compared to 12-23 months age group. At the same time, the adjusted number of cases of
pneumonia is lower compared to the adjusted number of cases of gastrointestinal disorder in two
different age groups. The only exceptions are on the left side of the graph, where region one and
region two with 12-23 months age group have higher pneumonia adjusted number of cases
compared to gastrointestinal disorder. Therefore, before the introduction of vaccination of both
infectious diseases, the incidence of pneumonia should be less than that of gastrointestinal
11

disorders.

Plot of Rate ratios, with size proportional to cross validation weights:
The dash line in this graph is rate ratio equal to one, which means there is no difference of
individuals getting infected post-vaccination compared to pre-vaccination. The points below the
dash line means that the overall rate ratio is lower than one, which means the number of
individuals getting infected post-vaccination is less than number of individuals getting infected
pre-vaccination.

J12_J18:
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By checking the synthetic controls model for effect of vaccines on pneumonia, the study shows
that the rate ratio for all the age groups in five regions of Brazil is lower than one. At the same
time, most of the age groups with four different analysis methods show similar rate ratio lower
than one.

A00_A09:
By checking the synthetic controls model for effect of vaccines on gastrointestinal disorders, the
study shows that the rate ratios for all the age groups in five regions of Brazil are distributed
either above the dash line or below it. Most of the synthetic controls rate ratios are close to one,
which is no different between post-vaccination and pre-vaccination. At the same time, most of
the age groups with four different analysis methods show similar rate ratio lower than one.
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Plot Observed vs expected yearly time series:
In these groups, horizontal black lines represent the expected number of cases derived from
synthetic controls estimate, while the black dots are real-life observed number of cases. The gray
area contains the black line are the 95% confidence interval for expected number of cases. The
vertical dash lines at year 2010 represent the time of introduction of vaccine for different regions
of Brazil.

J12_J18:
The first region for age group under 2 years old has lower number of cases for observed number
of cases compared to expected number of cases derived from synthetic controls estimate after
2010. The observed number of cases for age group 12 month to 23 month is out of the 95%
confidence interval of expected number of cases. However, the observed number of cases age
group under 12 months is within the 95% confidence interval of expected number of cases.
Similarly for region two, region three and region five, age group under 2 years old has lower
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number of cases for observed number of cases compared to the expected number of cases
derived from synthetic controls estimate after 2010. Additionally, both observed numbers of
cases for age groups are out of the 95% confidence interval of expected number of cases.
At last, region four for age group under 2 years old has lower number of cases for observed
number of cases compared to expected number of cases derived from synthetic controls
estimate after 2010. The observed number of cases for age under 12 month is out of the 95%
confidence interval of expected number of cases. However, the observed number of cases age
group between 12 month and 23 month is within the 95% confidence interval of expected
number of cases.
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A00_A09:
It is obvious that the confidence interval is much wider after year 2010 for the expected number
of cases generated from synthetic control estimated. In general, the first region for age group
under 2 years old has lower number of cases for observed number of cases compared to
16

expected number of cases derived from synthetic controls estimate after 2010. Both of the
observed number of cases for age group under 2 years old is out of the 95% confidence interval
of expected number of cases.
However, for all the other regions, the differences are not so obvious. For region two, three, four
and five, some of the observed numbers of cases are above the expected number of cases
generated from synthetic control estimated. Most of the observed numbers of cases are in the 95%
confidence interval of the generated expected number of cases.
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National level cumulative cases prevented for both vaccines:
J12_J18:
From these two graphs, the cumulative sum of incidence prevented for pneumonia increases
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significantly after the introduction of vaccine after 2010, which approximately reaching 60000 for
age group between 12 month and 23 month, and reaching over 90000 for age group below 12
month. The 95% confidence interval for both age groups are above the line of zero cumulative
sums prevented. At the same time, the 95% confidence interval for the cumulative sum is wider
for age group between 12 month and 23 month.

A00_A09:
From these two graphs, the cumulative sum of incidence prevented for gastrointestinal disorders
is not increased significantly after the introduction of vaccine after 2010 for age group between
12 month and 23month because the 95% confidence interval includes the zero cumulative sums
prevented in this age group. While for the age group under 12 month, the cumulative sum of
incidence prevented increased significantly with 95% confidence interval above the zero line for
cumulative sum. At the same time, the 95% confidence interval for the cumulative sum is wider
for age group between 12 month and 23 month.
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Discussion
Overall, the incidence counts of pneumonia are higher than the incidence counts of
gastrointestinal disorders in national and regional level. However, the regional differences were
observed as well. The only exception for the incidence counts of gastrointestinal disorders higher
than the incidence counts of pneumonia is region two. The incidence counts of pneumonia are
also higher in age group less than 12 months compared to age group between 12 month and 23
month, while the incidence counts of gastrointestinal disorders are similar for both age groups in
each region and in national level. In general, the prevalence of pneumonia is higher than
gastrointestinal disorders in younger patient population according to the hospitalization data.
Based on this knowledge, public health professionals and hospitals should prepare more vaccines
for pneumonia then vaccines for gastrointestinal disorders for younger patients in Brazil.
At the same time, there is no significant different between post-vaccination and pre-vaccination
for gastrointestinal disorders, which there is obvious lower rate ratio difference between
post-vaccination and pre-vaccination for pneumonia. The study shows that there is a significant
difference between the expected number of cases generated from synthetic control estimated
and the observed number of cases after the introduction of vaccines of pneumonia in all five
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different regions in Brazil. At the same time, the observed number of cases is generally
decreasing each year after the introduction of vaccine in 2010. Between two different age groups,
both show similar decreasing patterns after the introduction of vaccines. Unlikely vaccines of
pneumonia, the introduction of gastrointestinal disorders vaccines effect are only obvious in
region one for both age group. There is not a significant difference between the expected
number of cases generated from synthetic control estimated and the observed number of cases
for region two, three, four and five. Age group of between 12 month and 23 month even shows
an increased number of observed cases compared to expected number of cases generated from
the analysis. At the same time, the confidence interval after the introduction of vaccines in 2010
is wider for gastrointestinal disorders according to the analysis.
There is a significant increasing of the case prevented after the introduction of vaccine for
pneumonia for both age groups, while the cases prevented increase only shows in the age group
under 12 months after the introduction of vaccine for gastrointestinal disorders. Therefore, it is
obvious that the vaccination process greatly helps the prevention of pneumonia infections for
patients under two years old, and the effect of this vaccine is keeping increasing by observing the
steady increasing cases prevented over these years. In general, the vaccine for pneumonia is
significantly effective and could keep benefiting this population in the Brazil for the upcoming
future. However, unlike vaccine for pneumonia, the vaccine for gastrointestinal disorders shows
significant differences for two different age groups. It is hard to determine whether the vaccine is
effective for age group 12-23 months and under 12 months by considering confidence interval. It
is likely that the vaccination is more effective among older patients because patients under 12
months don’t expose to too many types of foods, which could potentially cause the
21

gastrointestinal disorders.

Limitations:
This study only concerns the younger age group, which are under 2-year-old patients with
hospitalization data of pneumonia and gastrointestinal disorders. It is possible that other age
groups with older patients could show different synthetic control results in different regions of
Brazil. Individuals with mature immune system could become less susceptible to infectious
diseases like pneumonia and gastrointestinal disorders. Because this study is conducted in a
regional and national level instead of state specific level, the geography characteristic is overall
more generalized and over-simplified. Geographic difference is an important factor that
influencing the prevalence and spreading of infectious diseases. Conditions like number of
hospitals, environment hygiene, social economic status, public health facilities and etc. could
contribute and impact the effect after the introduction of vaccine in different regions of Brazil. In
general, geographic differentiation is too general for this study.

Conclusion
The introduction of pneumonia vaccine in five regions of Brazil results in a significant increasing
in case prevented and decreasing in observed cases compared to synthetic control estimated
cases. However, unlike pneumonia vaccine, introduction of gastrointestinal disorder vaccine is
not significantly effective for certain region of Brazil in both age groups.
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EMD Competencies


Define the scope and worldwide impact of infectious diseases.



Describe the processes that drive transmission and maintenance of infectious agents.



Describe the epidemiology of the major infectious diseases worldwide as well as risk
exposures and behaviors as these relate to transmission.



Explain the interrelationship between the environment and the emergence and
maintenance of infectious diseases in populations.



Describe and critically evaluate approaches for the prevention and control of infectious
diseases and define the key issues to their effective use.



Apply principles and concepts obtained through coursework to design and implement
studies on the etiology, detection, prevention or control of infectious diseases in the
laboratory and field.
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